sábado, 4 de julio de 2020

Disaster Lit® Database Daily Updates | COVID-19

Disaster Lit® Database Daily Updates

Disaster Information and Emergency Response



07/02/2020 12:00 AM EDT

Source: European Union, European Centre for Disease Prevention and Control (ECDC). Published: 7/2/2020. While decreasing trends in disease incidence are being observed in Europe overall, this 28-page report details how there is still community transmission reported in most European Union/European Economic Area (EU/EEA) countries, the United Kingdom, and EU candidate and potential candidate countries. Additionally, some countries are reporting a resurgence of observed cases or large localized outbreaks. (PDF)
07/02/2020 12:00 AM EDT

Source: European Union, European Centre for Disease Prevention and Control (ECDC). Published: 7/2/2020. This six-page document aims to provide scientific evidence and guidance for healthcare settings and the public on using gloves as a preventive measure during the COVID-19 pandemic. It discusses how use of gloves in the community may lead to the misconception that hand hygiene practices can be neglected. (PDF)
07/02/2020 12:00 AM EDT

Source: U.S. Food and Drug Administration (FDA). Published: 7/2/2020. This four-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Centers for Disease Control and Prevention (CDC)'s Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay. Testing is to be conducted on specimens from individuals suspected of respiratory viral infection consistent with COVID-19 by a healthcare provider. Symptoms of respiratory viral infection due to SARS-CoV-2 and influenza can be similar. (PDF)
07/01/2020 12:00 AM EDT

Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 7/1/2020. The information on this web page is meant to assist health departments and homeless service providers in making decisions on the appropriate use of COVID-19 testing, including testing asymptomatic individuals with recent known or suspected exposure to SARS-CoV-2 to control transmission. (Text)
07/01/2020 12:00 AM EDT

Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 7/1/2020. This infographic provides details about Multi-System Inflammatory Syndrome in Children (MIS-C), including Epidemiology; MIS-C and COVID-19 Activity; Percentage of U.S. Children with MIS-C, by Race and Ethnicity; and Impact on the Cardiovascular System. (PDF)
07/01/2020 12:00 AM EDT

Source: Enhancing Learning and Research for Humanitarian Assistance (ELRHA). Published: 7/1/2020. This 163-page report identifies key evidence gaps that need to be filled through rigorous research if we are to identify solutions to prevent and protect health care from violence. It investigates the current status of research on violence against health care, identifies research gaps, and conducts an initial prioritization of future research. It is the result of research undertaken by RAND Europe, commissioned by the International Committee of the Red Cross (ICRC) and ELRHA. (PDF)
07/01/2020 12:00 AM EDT

Source: European Union, European Centre for Disease Prevention and Control (ECDC). Published: 7/1/2020. The European Union Aviation Safety Agency (EASA) and the European Centre for Disease Prevention and Control (ECDC) have developed these guidelines to serve as an aviation health safety protocol and to provide a source of best practice on how airport operators, airplane operators conducting commercial and non-commercial passenger transport operations, and national aviation authorities can ensure the health and safety of passengers, as well as the staff and crew who serve them, by maintaining safe and secure operations while minimizing the risk of COVID-19 virus transmission. (PDF)
07/01/2020 12:00 AM EDT

Source: U.S. Food and Drug Administration (FDA). Published: 7/1/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the CentoFast-SARS-CoV-2 RT-PCR Assay. The CentoFast-SARS-CoV-2 RT-PCR Assay is authorized for use with dry oropharyngeal swab specimens collected from individuals suspected of COVID-19 by their healthcare provider. (PDF)
06/19/2020 12:00 AM EDT

Source: National Academies of Sciences, Engineering, and Medicine. Published: 6/19/2020. This one-hour, 31-minute webinar features an overview of key patient-clinician communication challenges and disability law and policies applicable for accessible and effective communication during the COVID-19 pandemic, identifies techniques to facilitate health care communication with people with disabilities, and provides tools and resources to consider for better communication in the COVID world. (Video or Multimedia)
06/11/2020 12:00 AM EDT

Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 6/11/2020. The purpose of this 20-page tool is to facilitate a conversation between health departments and homeless service providers during the coronavirus disease 2019 (COVID-19) pandemic. It can also be a starting point for developing an infection prevention and control protocol for homeless service settings. (Text)
05/26/2020 12:00 AM EDT

Source: United Nations Office for the Coordination of Humanitarian Affairs (OCHA). Published: 5/26/2020. This 37-page guidance note is meant to assist humanitarian actors, youth-led organizations, and young people themselves across sectors, working at local, country, regional, and global levels in their response to the COVID-19 pandemic. It includes sections on health impacts, and safety and protection issues. (PDF)

No hay comentarios:

Publicar un comentario